Drostanolone Propionate ZPHC — 75 mg/ml

Drostanolone Propionate ZPHC — 75 mg/ml is a product described as containing drostanolone propionate, also known by the scientific name dromostanolone propionate. The stated presentation is 10 ampoules × 2 ml, with a concentration of 75 mg/ml.

According to the FDA Substance Registration System, dromostanolone propionate is a recognized chemical substance with the molecular formula C₂₃H₃₆O₃ and molecular weight of approximately 360.53 g/mol.

For U.S. audiences, regulatory status is particularly important. FDA records identify dromostanolone propionate as associated with the Schedule III anabolic-steroid classification, while the DEA identifies anabolic steroids as Schedule III controlled substances.

Product Specifications

• Product: Drostanolone Propionate ZPHC
• Concentration: 75 mg/ml
• Presentation: 10 ampoules × 2 ml
• Total volume: 20 ml
• Active substance: Drostanolone propionate / dromostanolone propionate
• Chemical formula: C₂₃H₃₆O₃
• Molecular weight: 360.53 g/mol
• Category: Anabolic-androgenic steroid

The stated concentration means each 2 ml ampoule contains 150 mg of the active substance by the stated concentration, resulting in a nominal total of 1,500 mg across 10 ampoules. These figures describe the supplied specifications and should not be interpreted as a recommended dose or treatment regimen.

Understanding Drostanolone Propionate

Drostanolone is an androgenic anabolic steroid derived from the androgen family. FDA’s substance database lists dromostanolone propionate under several names, including drostanolone propionate, dromostanolone propionate, and Drolban, helping distinguish the compound from similarly named substances.

The propionate component refers to the ester attached to the steroid molecule. Product formulations containing esterified compounds can differ in their pharmaceutical characteristics, but consumers should not interpret the presence of a particular ester as evidence that a product is appropriate for personal use.

ZPHC Product Information

The name ZPHC identifies the manufacturer or product branding stated in the supplied product information. However, the presence of a brand name alone does not establish that a particular online product has been evaluated, approved, authenticated, or legally authorized for sale in the United States.

FDA specifically notes that information in its substance-registration systems concerns identification and registration data and does not itself constitute regulatory approval.

Consequently, product descriptions should distinguish between chemical identity, manufacturer claims, and regulatory authorization.

U.S. Regulatory Considerations

Anyone researching Drostanolone Propionate ZPHC in the United States should understand the applicable controlled-substance framework before considering the product.

The FDA’s database identifies dromostanolone propionate with a DEA classification reference for Schedule III anabolic steroids. The DEA likewise explains that anabolic steroids fall under Schedule III and describes them as controlled substances under federal law.

The DEA also warns that illicit anabolic steroids are frequently sold through the internet and that products obtained from unauthorized sources can present significant concerns regarding authenticity and legal status.

This makes verification of legitimate medical and pharmaceutical channels especially important for U.S. consumers.

Quality and Authentication Considerations

When researching an injectable steroid product, product appearance or packaging should not be treated as proof of authenticity. Important considerations can include:

• Manufacturer identification
• Lot or batch information
• Expiration information
• Appropriate labeling
• Packaging integrity
• Traceability through a legitimate pharmaceutical supply chain
• Applicable regulatory authorization
• Professional medical oversight

An attractive package, ampoule design, or website description cannot independently establish the identity or purity of an injectable substance.

Safety Information

Drostanolone belongs to the anabolic-androgenic steroid category. The DEA describes anabolic steroids as synthetic variants of testosterone used in attempts to promote muscle growth, physical performance, or changes in physical appearance.

Non-medical use can involve substantial risks. The DEA notes that anabolic steroids may be taken in doses far above approved therapeutic or medical treatment doses and that people may combine multiple anabolic steroids in cycles.

Because this product is an injectable controlled anabolic steroid, it should not be treated like an ordinary nutritional supplement or over-the-counter wellness product.

Why Accurate Product Information Matters

Accurate SEO content should avoid unsupported claims such as guaranteed muscle growth, guaranteed fat loss, enhanced athletic performance, or specific medical outcomes. Such claims can create unrealistic expectations and may incorrectly imply that an unverified product has established safety or efficacy.

A more reliable product page focuses on objectively verifiable information: compound identity, concentration, package configuration, chemical characteristics, regulatory classification, and appropriate safety considerations.

For U.S. readers researching ZPHC Drostanolone Propionate 75 mg/ml, these details provide a clearer basis for understanding what the product is and what regulatory considerations surround it.

Frequently Asked Questions

What is Drostanolone Propionate?

Drostanolone propionate is the propionate ester of dromostanolone. FDA records identify dromostanolone propionate as a distinct chemical substance and provide its molecular formula and other identifying information.

How much product is in this presentation?

The stated package contains 10 ampoules of 2 ml each, giving a total stated volume of 20 ml.

What is the stated concentration?

The supplied product specification states 75 mg/ml.

Is drostanolone propionate a controlled substance in the United States?

FDA records associate dromostanolone propionate with the DEA Schedule III anabolic-steroid classification, and the DEA identifies anabolic steroids as Schedule III controlled substances.

Is this an ordinary dietary supplement?

No. Drostanolone is an anabolic steroid rather than an ordinary dietary supplement. The DEA specifically distinguishes anabolic steroids from conventional supplement products.

What should consumers verify?

Consumers should verify the product’s identity, labeling, manufacturer information, lot information, regulatory status, and legitimate pharmaceutical supply chain rather than relying solely on online marketing claims.

Final Product Overview

Drostanolone Propionate ZPHC — 75 mg/ml (10 ampoules × 2 ml) is a specified injectable preparation containing the anabolic steroid drostanolone propionate. Its stated configuration is 10 × 2 ml ampoules at 75 mg/ml. FDA records provide established chemical-identification information for dromostanolone propionate, while U.S. regulatory records place the substance within the Schedule III anabolic-steroid framework.

For anyone researching this product in the United States, the most important considerations are accurate identification, authenticity, legal status, and appropriate medical oversight rather than promotional claims.